Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Cumberland Pharmaceuticals (CPIX) Misses Q1 EPS by 14c, Revenues Miss
May 20, 2020 4:10 PM EDTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.12), $0.14 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $8.33 million versus the consensus estimate of $9.46 million.
"Our thoughts go out to those currently suffering from the novel coronavirus pandemic,... More
